Answer
Ponesimod targets sphingosine 1-phosphate receptor 1 (S1P1), binding with high affinity to this receptor on lymphocytes and acting as a modulator.
Sources for this answer
- Ponvory 20 mg film-coated tabletsLaboratoires Juvise Pharmaceuticals · emc · SmPC §5.1 Pharmacodynamic properties · Version 3Document updated
Sources checked